ADMA Biologics (ADMA) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

ADMA Biologics Revenue Highlights

Latest Revenue (Y)

$426.45M

Latest Revenue (Q)

$119.84M

Main Segment (Y)

ADMA BioManufacturing Segment

Main Geography (Y)

United States

ADMA Biologics Revenue by Period

ADMA Biologics Revenue by Year

Date	Revenue	Change
2024-12-31	$426.45M	65.15%
2023-12-31	$258.21M	67.59%
2022-12-31	$154.08M	90.36%
2021-12-31	$80.94M	91.72%
2020-12-31	$42.22M	43.85%
2019-12-31	$29.35M	72.79%
2018-12-31	$16.99M	-25.37%
2017-12-31	$22.76M	113.49%
2016-12-31	$10.66M	48.53%
2015-12-31	$7.18M	21.34%
2014-12-31	$5.92M	92.84%
2013-12-31	$3.07M	174.35%
2012-12-31	$1.12M	100.00%
2011-06-30	-	100.00%
2010-06-30	-	100.00%
2009-06-30	-	100.00%
2008-06-30	-	100.00%
2007-06-30	-	-

ADMA Biologics generated $426.45M in revenue during NA 2024, up 65.15% compared to the previous quarter, and up 1453.04% compared to the same period a year ago.

ADMA Biologics Revenue by Quarter

Date	Revenue	Change
2024-09-30	$119.84M	11.80%
2024-06-30	$107.19M	30.92%
2024-03-31	$81.88M	10.79%
2023-12-31	$73.90M	9.85%
2023-09-30	$67.27M	11.89%
2023-06-30	$60.12M	5.64%
2023-03-31	$56.91M	13.87%
2022-12-31	$49.98M	21.64%
2022-09-30	$41.09M	21.19%
2022-06-30	$33.91M	16.50%
2022-03-31	$29.10M	10.31%
2021-12-31	$26.38M	27.57%
2021-09-30	$20.68M	15.98%
2021-06-30	$17.83M	11.10%
2021-03-31	$16.05M	14.99%
2020-12-31	$13.96M	35.81%
2020-09-30	$10.28M	31.96%
2020-06-30	$7.79M	-23.65%
2020-03-31	$10.20M	-15.26%
2019-12-31	$12.04M	66.66%
2019-09-30	$7.22M	10.08%
2019-06-30	$6.56M	85.94%
2019-03-31	$3.53M	-13.01%
2018-12-31	$4.06M	-4.11%
2018-09-30	$4.23M	-9.15%
2018-06-30	$4.66M	15.20%
2018-03-31	$4.04M	-66.32%
2017-12-31	$12.00M	153.79%
2017-09-30	$4.73M	39.12%
2017-06-30	$3.40M	29.31%
2017-03-31	$2.63M	-21.00%
2016-12-31	$3.33M	13.26%
2016-09-30	$2.94M	29.32%
2016-06-30	$2.27M	6.96%
2016-03-31	$2.12M	-15.46%
2015-12-31	$2.51M	35.62%
2015-09-30	$1.85M	41.41%
2015-06-30	$1.31M	-12.85%
2015-03-31	$1.50M	0.97%
2014-12-31	$1.49M	8.99%
2014-09-30	$1.37M	-8.96%
2014-06-30	$1.50M	-3.86%
2014-03-31	$1.56M	268.03%
2013-12-31	$424.03K	-61.71%
2013-09-30	$1.11M	48.98%
2013-06-30	$743.27K	-6.26%
2013-03-31	$792.93K	51.53%
2012-12-31	$523.28K	45.22%
2012-09-30	$360.34K	56.60%
2012-06-30	$230.10K	5129.45%
2012-03-31	$4.40K	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-09-30	-	-

ADMA Biologics generated $119.84M in revenue during Q3 2024, up 11.80% compared to the previous quarter, and up 199.32% compared to the same period a year ago.

ADMA Biologics Revenue Breakdown

ADMA Biologics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 19
ADMA BioManufacturing Segment	$415.81M	$161.16M	-	-	-
Plasma Collection Centers Segment	$11.30M	$8.12M	-	-	-
License Revenue	-	-	$142.83K	$142.83K	-
Product Revenue	-	-	$153.94M	$80.80M	-
Plasma Collection Centers	-	-	-	-	$7.03M
Corporate	-	-	-	-	$142.83K
ADMA BioManufacturing	-	-	-	-	$22.18M

ADMA Biologics's latest annual revenue breakdown by segment (product or service), as of Dec 24: ADMA BioManufacturing Segment (97.36%), and Plasma Collection Centers Segment (2.64%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
ADMA BioManufacturing Segment	$222.60M	$113.09M	$80.11M	$51.82M	$59.76M	$49.58M	-	-	-	-	-	-	-	-	-	-	-	-
Plasma Collection Centers Segment	$2.07M	$7.45M	$1.78M	$488.76K	$326.35K	$7.30M	-	-	-	-	-	-	-	-	-	-	-	-
Corporate Segment	-	$36.00K	$36.00K	$35.71K	$35.71K	-	-	-	-	-	-	-	-	-	-	-	-	-
License Revenue	-	-	-	-	-	-	$35.71K	$35.71K	$35.71K	$35.71K	$35.71K	$35.71K	$35.71K	-	-	-	-	-
Product Revenue	-	-	-	-	-	-	$49.95M	$41.05M	$33.87M	$29.07M	$26.35M	$20.64M	$17.79M	-	-	-	-	-
Plasma Collection Centers	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.42M	$1.04M	$1.32M	$2.52M	$2.15M
ADMA BioManufacturing	-	-	-	-	-	-	-	-	-	-	-	-	-	$7.74M	$10.96M	$5.87M	$4.00M	$1.34M
Corporate	-	-	-	-	-	-	-	-	-	-	-	-	-	$35.71K	$35.71K	$35.71K	$35.71K	$35.71K

ADMA Biologics's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: ADMA BioManufacturing Segment (99.08%), and Plasma Collection Centers Segment (0.92%).

ADMA Biologics Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 22
International	$16.31M	-
United States	$410.15M	$146.43M

ADMA Biologics's latest annual revenue breakdown by geography, as of Dec 24: United States (96.18%), and International (3.82%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
International	$7.33M	$5.09M	$3.88M	-	-	-	-	-	-
United States	$217.41M	$114.75M	$77.99M	$56.61M	$52.69M	$49.98M	$37.85M	$31.27M	$27.32M

ADMA Biologics's latest quarterly revenue breakdown by geography, as of Dec 24: United States (96.74%), and International (3.26%).

ADMA Biologics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BCRX	BioCryst Pharmaceuticals	$450.71M	$117.08M
ADMA	ADMA Biologics	$426.45M	$119.84M
RCUS	Arcus Biosciences	$258.00M	$48.00M
MDGL	Madrigal Pharmaceuticals	$180.13M	$62.17M
AKBA	Akebia Therapeutics	$160.18M	$35.59M
ATRA	Atara Biotherapeutics	$128.94M	$40.19M
ACLX	Arcellx	$107.94M	$26.03M
STOK	Stoke Therapeutics	$36.55M	$4.89M
VXRT	Vaxart	$28.70M	$4.93M
FATE	Fate Therapeutics	$13.63M	$6.77M
TNXP	Tonix Pharmaceuticals	$10.09M	$2.82M
XFOR	X4 Pharmaceuticals	$2.56M	$560.00K
CDTX	Cidara Therapeutics	$1.27M	-
INMB	INmune Bio	$14.00K	-
ANEB	Anebulo Pharmaceuticals	-	-
ETNB	89bio	-	-
MCRB	Seres Therapeutics	-	-
ANTX	AN2 Therapeutics	-	-
SANA	Sana Bio	-	-
CRBU	Caribou Biosciences	-	$3.46M
PLRX	Pliant Therapeutics	-	-

ADMA Revenue FAQ

What is ADMA Biologics’s yearly revenue?

ADMA Biologics's yearly revenue for 2024 was $426.45M, representing an increase of 65.15% compared to 2023. The company's yearly revenue for 2023 was $258.21M, representing an increase of 67.59% compared to 2022. ADMA's yearly revenue for 2022 was $154.08M, representing an increase of 90.36% compared to 2021.

What is ADMA Biologics’s quarterly revenue?

ADMA Biologics's quarterly revenue for Q3 2024 was $119.84M, a 11.80% increase from the previous quarter (Q2 2024), and a 78.13% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $107.19M, a 30.92% increase from the previous quarter (Q1 2024), and a 78.29% increase year-over-year (Q2 2023). ADMA's quarterly revenue for Q1 2024 was $81.88M, a 10.79% increase from the previous quarter (Q4 2023), and a 43.86% increase year-over-year (Q1 2023).

What is ADMA Biologics’s revenue growth rate?

ADMA Biologics's revenue growth rate for the last 3 years (2022-2024) was 176.77%, and for the last 5 years (2020-2024) was 910.08%.

What are ADMA Biologics’s revenue streams?

ADMA Biologics's revenue streams in c 24 are ADMA BioManufacturing Segment, and Plasma Collection Centers Segment. ADMA BioManufacturing Segment generated $415.81M in revenue, accounting 97.36% of the company's total revenue, up 158.01% year-over-year. Plasma Collection Centers Segment generated $11.3M in revenue, accounting 2.64% of the company's total revenue, up 39.18% year-over-year.

What is ADMA Biologics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of ADMA Biologics was ADMA BioManufacturing Segment. This segment made a revenue of $415.81M, representing 97.36% of the company's total revenue.